| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vincerx Pharma, Inc. (VINC) has 0 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. VINC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Seelenberger Alexander A. | See Remarks | Buy | 10,500 | $0.95 | $9,967.65 | +53.1% | |
| Aug 10, 2023 | Thomas Tom C | See Remarks | Buy | 5,000 | $0.95 | $4,750.00 | +2.3% | |
| Aug 10, 2023 | Hamdy Ahmed Md | See Remarks | Buy | 22,300 | $0.95 | $21,161.42 | +13.6% | |
| Aug 10, 2023 | Izumi Raquel E. | See Remarks | Buy | 16,476 | $0.91 | $14,934.21 | +10.9% | |
| Dec 14, 2022 | Hamdy Ahmed Md | Chief Executive Officer | Buy | 35,280 | $0.87 | $30,538.37 | +91.7% | |
| Dec 14, 2022 | Izumi Raquel E. | See Remarks | Buy | 28,738 | $0.88 | $25,427.38 | +71.8% | |
| Dec 14, 2022 | Thomas Tom C | See Remarks | Buy | 7,000 | $0.83 | $5,810.00 | +233.3% | |
| Aug 25, 2022 | Lowe Christopher P.77 | Director | Buy | 30,000 | $1.65 | $49,438.12 | +78.1% | |
| Jun 27, 2022 | Izumi Raquel E. | See Remarks | Buy | 40,000 | $1.41 | $56,312.00 | New | |
| Jun 23, 2022 | Hamdy Ahmed Md | Chief Executive Officer | Buy | 24,200 | $1.41 | $34,136.52 | +169.5% |